Brian T. Kawasaki, Ph.D.
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Google:
"Brian Kawasaki"Mean distance: 18.39 (cluster 31) | S | N | B | C | P |
Parents
Sign in to add mentor| Lutz Birnbaumer | grad student | 2005 | UCLA | |
| (Players in the regulation of calcium entry: Activation of the transient receptor potential channels by src tyrosine kinase and a distinct role for the IP3 receptor C-terminus in store- and receptor -operated calcium entry.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Volate SR, Kawasaki BT, Hurt EM, et al. (2010) Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Molecular Cancer Therapeutics. 9: 461-70 |
| Kawasaki BT, Hurt EM, Kalathur M, et al. (2009) Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. The Prostate. 69: 827-37 |
| Hurt EM, Klarmann GJ, Kawasaki BT, et al. (2009) Prostate cancer stem cells Stem Cells and Cancer. 137-165 |
| Kawasaki BT, Hurt EM, Mistree T, et al. (2008) Targeting cancer stem cells with phytochemicals. Molecular Interventions. 8: 174-84 |
| Qin HR, Kim HJ, Kim JY, et al. (2008) Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Research. 68: 7736-41 |
| Kawasaki BT, Farrar WL. (2008) Cancer stem cells, CD200 and immunoevasion. Trends in Immunology. 29: 464-8 |
| Hurt EM, Kawasaki BT, Klarmann GJ, et al. (2008) CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer. 98: 756-65 |
| Kawasaki BT, Mistree T, Hurt EM, et al. (2007) Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochemical and Biophysical Research Communications. 364: 778-82 |
| Sharifi N, Hurt EM, Kawasaki BT, et al. (2007) TGFBR3 loss and consequences in prostate cancer. The Prostate. 67: 301-11 |
| Sharifi N, Kawasaki BT, Hurt EM, et al. (2006) Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy. Cancer Biology & Therapy. 5: 901-6 |